[Generalized mycoses and their therapy].
After valuation of the increasing significance of the medical mycology as an interdisciplinary branch of science which concerns all clinicians the causes for the permanent increase of the endomycoses by yeasts and moulds are demonstrated. As secondary mycoses they need predisposing factors for manifestation which are to be taken into consideration more than up to now done in so-called risk patients. The pathomechanism is demonstrated with the help of the frequency of the lesion of organic systems in candidoses as well as in mould mycoses. Finally, the modern therapeutic possibilities are discussed.
D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D006801:Humans; D009091:Mucormycosis / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy*; D010407:Penicillium
D000935:Antifungal Agents
Generalisierte Mykosen und ihre Therapie.